Skip to content
Industry
This is research, not advice. We’re not SEBI-registered.

Stevanato Group S.p.A. share price today

Stevanato Group S.p.A. · STVN · Healthcare · Medical Instruments & Supplies · price as of the 4 November 2026 close, updated every trading day · results updated weekly · All US stock lists

Stevanato Group S.p.A. share price: $13.44 at the close on 4 November 2026, −44.2% in a year.

MixedBusiness trend from the last 12 quarters
$13.44Price −44.2% in a year
23.2×P/E over 4.6 years
$302 MRevenue (Jun 2026) +7.8% on a year ago
$23.0 MProfit (Jun 2026) −22.7% on a year ago
17.2%Operating margin +2.2 points on a year ago
9%ROE FY25
8.1%ROIC against a 7.7% cost of capital: +0.4 points

Stevanato Group S.p.A.'s earnings have grown faster than its share price. Earnings per share grew +18.6% in a year while the price moved −44.2%.

The main question: yearly earnings per share moved +18.6% while the share price moved −44.2%.

The price has been falling for 1 weeks. Over the last four quarters, results have been improving, with profit −22.7% on a year earlier, and 136% of the last 3 years' profit came in as cash. What will decide it: whether the price catches up with earnings that have already grown.

What is the Stevanato Group S.p.A. share price today?

Stevanato Group S.p.A.'s share price was $13.44 at the close on 4 November 2026. It has been falling for 1 week. That is 25.5% below its average price over the last 200 trading days. In the last 52 weeks it traded between $13 and $24, and at that close it was at the low of that range.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Stevanato Group S.p.A. is in stage 4. The phase helps read everything below.

Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 5 weeks running.

1Y

Nov 2026: $13.44, 25.5% below its 200-day average. The price has been falling for 1 week.

  • Price $13.44
  • 50-day avg $20.17
  • 200-day avg $18.04
Nov 2026: $13.44, 25.5% below its 200-day average. The price has been falling for 1 week.
WeekPrice50-day avg200-day avg
31 Oct 2025$25.22$25.12$23.15
7 Nov 2025$24.10$25.34$23.21
14 Nov 2025$22.08$25.35$23.26
21 Nov 2025$22.38$24.87$23.24
28 Nov 2025$23.36$24.58$23.29
5 Dec 2025$22.11$24.19$23.36
12 Dec 2025$20.82$23.72$23.37
19 Dec 2025$20.53$23.33$23.41
26 Dec 2025$20.70$23.09$23.40
2 Jan 2026$20.58$22.71$23.40
9 Jan 2026$21.06$22.23$23.39
16 Jan 2026$19.75$21.77$23.39
23 Jan 2026$17.27$21.31$23.36
30 Jan 2026$15.58$20.67$23.25
6 Feb 2026$15.50$19.99$23.08
13 Feb 2026$16.01$19.28$22.93
20 Feb 2026$16.05$18.77$22.83
27 Feb 2026$15.52$18.20$22.65
6 Mar 2026$15.41$17.71$22.45
13 Mar 2026$14.99$17.15$22.24
20 Mar 2026$14.60$16.56$22.06
27 Mar 2026$13.43$15.88$21.83
2 Apr 2026$13.73$15.39$21.62
10 Apr 2026$13.52$15.02$21.36
17 Apr 2026$15.53$14.95$21.11
24 Apr 2026$16.18$15.00$20.89
1 May 2026$17.71$15.07$20.67
8 May 2026$18.23$15.33$20.50
15 May 2026$17.99$15.57$20.30
22 May 2026$18.01$15.82$20.13
29 May 2026$18.66$16.07$20.04
5 Jun 2026$18.46$16.47$19.95
12 Jun 2026$17.08$16.86$19.83
18 Jun 2026$17.54$17.12$19.71
26 Jun 2026$17.84$17.45$19.53
2 Jul 2026$19.00$17.67$19.37
10 Jul 2026$19.59$18.02$19.18
17 Jul 2026$19.17$18.23$19.02
24 Jul 2026$19.68$18.33$18.86
31 Jul 2026$19.85$18.56$18.76
7 Aug 2026$20.27$18.79$18.65
14 Aug 2026$21.06$19.02$18.52
21 Aug 2026$22.60$19.40$18.43
28 Aug 2026$21.03$19.92$18.37
4 Sep 2026$20.51$20.26$18.32
11 Sep 2026$20.90$20.48$18.30
18 Sep 2026$21.70$20.73$18.28
25 Sep 2026$21.13$20.92$18.25
2 Oct 2026$20.20$21.07$18.24
9 Oct 2026$19.40$21.02$18.22
16 Oct 2026$18.90$20.93$18.18
23 Oct 2026$19.49$20.76$18.13
30 Oct 2026$19.38$20.58$18.10
4 Nov 2026$13.44$20.17$18.04
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 1-year window.

3Y

Nov 2026: $13.44, 25.5% below its 200-day average. The price has been falling for 1 week.

  • Price $13.44
  • 50-day avg $20.17
  • 200-day avg $18.04
Nov 2026: $13.44, 25.5% below its 200-day average. The price has been falling for 1 week.
WeekPrice50-day avg200-day avg
3 Nov 2023$26.67$30.55$27.92
10 Nov 2023$28.61$30.00$28.10
17 Nov 2023$27.19$29.67$28.31
24 Nov 2023$27.91$29.52$28.47
1 Dec 2023$27.41$29.28$28.61
8 Dec 2023$27.82$29.14$28.76
15 Dec 2023$28.31$28.91$28.90
22 Dec 2023$27.34$28.38$28.99
29 Dec 2023$27.29$27.86$29.08
5 Jan 2024$26.33$27.35$29.13
12 Jan 2024$27.62$27.21$29.23
19 Jan 2024$28.34$27.33$29.28
26 Jan 2024$31.72$27.56$29.39
2 Feb 2024$33.06$28.01$29.52
9 Feb 2024$32.60$28.71$29.70
16 Feb 2024$31.67$29.33$29.85
23 Feb 2024$32.17$29.62$29.92
1 Mar 2024$32.59$30.02$30.02
8 Mar 2024$29.35$30.40$30.14
15 Mar 2024$29.98$30.65$30.19
22 Mar 2024$31.01$30.89$30.23
28 Mar 2024$32.10$31.21$30.29
5 Apr 2024$28.98$31.35$30.26
12 Apr 2024$29.39$31.10$30.19
19 Apr 2024$26.73$30.57$30.10
26 Apr 2024$27.54$29.99$29.98
3 May 2024$26.45$29.63$29.86
10 May 2024$21.82$28.92$29.67
17 May 2024$20.71$27.82$29.41
24 May 2024$19.97$26.89$29.07
31 May 2024$20.32$26.13$28.82
7 Jun 2024$18.62$24.95$28.52
14 Jun 2024$17.77$23.69$28.16
21 Jun 2024$17.79$22.78$27.87
28 Jun 2024$18.34$21.63$27.55
5 Jul 2024$18.53$20.92$27.33
12 Jul 2024$21.71$20.17$27.14
19 Jul 2024$21.38$19.61$26.95
26 Jul 2024$19.60$19.42$26.69
2 Aug 2024$19.21$19.37$26.34
9 Aug 2024$20.39$19.38$26.01
16 Aug 2024$19.88$19.44$25.77
23 Aug 2024$18.60$19.50$25.58
30 Aug 2024$21.88$19.79$25.41
6 Sep 2024$21.37$20.13$25.28
13 Sep 2024$19.27$20.29$25.09
20 Sep 2024$19.26$20.29$24.92
27 Sep 2024$21.33$20.17$24.76
4 Oct 2024$18.97$20.03$24.56
11 Oct 2024$19.00$19.90$24.33
18 Oct 2024$18.32$19.78$24.12
25 Oct 2024$17.27$19.56$23.90
1 Nov 2024$19.59$19.51$23.68
8 Nov 2024$21.78$19.68$23.48
15 Nov 2024$19.00$19.56$23.19
22 Nov 2024$19.65$19.44$22.81
29 Nov 2024$20.03$19.48$22.55
6 Dec 2024$20.48$19.49$22.28
13 Dec 2024$23.31$19.65$22.03
20 Dec 2024$20.56$20.02$21.78
27 Dec 2024$21.61$20.25$21.63
3 Jan 2025$23.68$20.58$21.49
10 Jan 2025$22.94$21.04$21.37
17 Jan 2025$22.85$21.35$21.14
24 Jan 2025$21.54$21.30$20.98
31 Jan 2025$22.41$21.41$20.79
7 Feb 2025$21.93$21.76$20.64
14 Feb 2025$19.54$21.76$20.46
21 Feb 2025$20.90$21.78$20.32
28 Feb 2025$18.64$21.62$20.21
7 Mar 2025$21.56$21.36$20.17
14 Mar 2025$20.03$21.30$20.19
21 Mar 2025$22.51$21.15$20.24
28 Mar 2025$20.29$21.00$20.30
4 Apr 2025$19.02$20.81$20.35
11 Apr 2025$21.91$20.68$20.42
17 Apr 2025$21.86$20.68$20.50
25 Apr 2025$21.59$20.74$20.58
2 May 2025$21.38$20.86$20.58
9 May 2025$24.00$21.03$20.60
16 May 2025$24.02$21.49$20.69
23 May 2025$22.31$21.75$20.79
30 May 2025$22.21$21.89$20.85
6 Jun 2025$23.74$21.98$20.91
13 Jun 2025$23.48$22.33$21.03
20 Jun 2025$23.29$22.70$21.09
27 Jun 2025$24.64$23.00$21.17
3 Jul 2025$24.59$23.22$21.27
11 Jul 2025$25.21$23.56$21.41
18 Jul 2025$24.90$23.98$21.53
25 Jul 2025$26.51$24.22$21.68
1 Aug 2025$25.12$24.34$21.85
8 Aug 2025$23.63$24.45$21.99
15 Aug 2025$22.62$24.45$22.10
22 Aug 2025$22.62$24.32$22.19
29 Aug 2025$23.01$24.18$22.21
5 Sep 2025$24.15$24.11$22.26
12 Sep 2025$26.42$24.26$22.45
19 Sep 2025$26.80$24.46$22.63
26 Sep 2025$25.66$24.54$22.78
3 Oct 2025$25.98$24.60$22.88
10 Oct 2025$23.85$24.48$22.93
17 Oct 2025$24.44$24.43$23.00
24 Oct 2025$26.11$24.83$23.08
31 Oct 2025$25.22$25.12$23.15
7 Nov 2025$24.10$25.34$23.21
14 Nov 2025$22.08$25.35$23.26
21 Nov 2025$22.38$24.87$23.24
28 Nov 2025$23.36$24.58$23.29
5 Dec 2025$22.11$24.19$23.36
12 Dec 2025$20.82$23.72$23.37
19 Dec 2025$20.53$23.33$23.41
26 Dec 2025$20.70$23.09$23.40
2 Jan 2026$20.58$22.71$23.40
9 Jan 2026$21.06$22.23$23.39
16 Jan 2026$19.75$21.77$23.39
23 Jan 2026$17.27$21.31$23.36
30 Jan 2026$15.58$20.67$23.25
6 Feb 2026$15.50$19.99$23.08
13 Feb 2026$16.01$19.28$22.93
20 Feb 2026$16.05$18.77$22.83
27 Feb 2026$15.52$18.20$22.65
6 Mar 2026$15.41$17.71$22.45
13 Mar 2026$14.99$17.15$22.24
20 Mar 2026$14.60$16.56$22.06
27 Mar 2026$13.43$15.88$21.83
2 Apr 2026$13.73$15.39$21.62
10 Apr 2026$13.52$15.02$21.36
17 Apr 2026$15.53$14.95$21.11
24 Apr 2026$16.18$15.00$20.89
1 May 2026$17.71$15.07$20.67
8 May 2026$18.23$15.33$20.50
15 May 2026$17.99$15.57$20.30
22 May 2026$18.01$15.82$20.13
29 May 2026$18.66$16.07$20.04
5 Jun 2026$18.46$16.47$19.95
12 Jun 2026$17.08$16.86$19.83
18 Jun 2026$17.54$17.12$19.71
26 Jun 2026$17.84$17.45$19.53
2 Jul 2026$19.00$17.67$19.37
10 Jul 2026$19.59$18.02$19.18
17 Jul 2026$19.17$18.23$19.02
24 Jul 2026$19.68$18.33$18.86
31 Jul 2026$19.85$18.56$18.76
7 Aug 2026$20.27$18.79$18.65
14 Aug 2026$21.06$19.02$18.52
21 Aug 2026$22.60$19.40$18.43
28 Aug 2026$21.03$19.92$18.37
4 Sep 2026$20.51$20.26$18.32
11 Sep 2026$20.90$20.48$18.30
18 Sep 2026$21.70$20.73$18.28
25 Sep 2026$21.13$20.92$18.25
2 Oct 2026$20.20$21.07$18.24
9 Oct 2026$19.40$21.02$18.22
16 Oct 2026$18.90$20.93$18.18
23 Oct 2026$19.49$20.76$18.13
30 Oct 2026$19.38$20.58$18.10
4 Nov 2026$13.44$20.17$18.04
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 3-year window.

5Y

Nov 2026: $13.44, 25.5% below its 200-day average. The price has been falling for 1 week.

  • Price $13.44
  • 50-day avg $20.17
  • 200-day avg $18.04
Nov 2026: $13.44, 25.5% below its 200-day average. The price has been falling for 1 week.
WeekPrice50-day avg200-day avg
29 Oct 2021$25.67$25.61–
12 Nov 2021$22.20$25.48–
26 Nov 2021$22.39$24.66–
10 Dec 2021$22.47$23.92–
23 Dec 2021$23.33$23.80–
7 Jan 2022$17.97$23.04–
21 Jan 2022$18.43$21.65–
4 Feb 2022$17.49$20.65–
18 Feb 2022$16.29$19.45–
4 Mar 2022$16.68$18.23–
18 Mar 2022$17.76$17.03–
1 Apr 2022$20.26$17.23–
14 Apr 2022$19.94$17.59–
29 Apr 2022$16.00$17.51–
13 May 2022$15.32$17.24$20.95
27 May 2022$16.83$17.27$20.73
10 Jun 2022$14.84$16.86$20.43
24 Jun 2022$16.14$16.11$19.95
8 Jul 2022$15.27$15.66$19.45
22 Jul 2022$15.12$15.57$18.89
5 Aug 2022$18.27$15.89$18.55
19 Aug 2022$16.56$16.15$18.15
2 Sep 2022$16.43$16.45$17.80
16 Sep 2022$17.41$16.82$17.57
30 Sep 2022$16.94$17.29$17.29
14 Oct 2022$18.51$17.46$17.02
28 Oct 2022$16.95$17.52$16.94
11 Nov 2022$15.41$17.12$16.81
25 Nov 2022$14.90$16.61$16.66
9 Dec 2022$16.73$16.27$16.64
23 Dec 2022$17.89$16.29$16.70
6 Jan 2023$20.00$16.26$16.77
20 Jan 2023$19.60$16.98$16.79
3 Feb 2023$19.59$18.06$16.83
17 Feb 2023$21.21$19.08$17.02
3 Mar 2023$25.40$19.95$17.34
17 Mar 2023$23.14$21.06$17.70
31 Mar 2023$25.90$21.95$18.11
14 Apr 2023$26.81$23.04$18.59
28 Apr 2023$26.51$24.32$19.15
12 May 2023$27.71$25.54$19.76
26 May 2023$26.70$26.22$20.23
9 Jun 2023$28.99$27.00$20.70
23 Jun 2023$32.08$28.02$21.36
7 Jul 2023$31.80$28.91$22.00
21 Jul 2023$32.88$29.94$22.74
4 Aug 2023$32.87$30.89$23.45
18 Aug 2023$30.96$31.90$24.17
1 Sep 2023$33.28$32.16$25.05
15 Sep 2023$29.37$31.85$25.75
29 Sep 2023$29.72$31.12$26.37
13 Oct 2023$33.04$31.10$27.08
27 Oct 2023$28.72$30.99$27.74
10 Nov 2023$28.61$30.00$28.10
24 Nov 2023$27.91$29.52$28.47
8 Dec 2023$27.82$29.14$28.76
22 Dec 2023$27.34$28.38$28.99
5 Jan 2024$26.33$27.35$29.13
19 Jan 2024$28.34$27.33$29.28
2 Feb 2024$33.06$28.01$29.52
16 Feb 2024$31.67$29.33$29.85
1 Mar 2024$32.59$30.02$30.02
15 Mar 2024$29.98$30.65$30.19
28 Mar 2024$32.10$31.21$30.29
12 Apr 2024$29.39$31.10$30.19
26 Apr 2024$27.54$29.99$29.98
10 May 2024$21.82$28.92$29.67
24 May 2024$19.97$26.89$29.07
7 Jun 2024$18.62$24.95$28.52
21 Jun 2024$17.79$22.78$27.87
5 Jul 2024$18.53$20.92$27.33
19 Jul 2024$21.38$19.61$26.95
2 Aug 2024$19.21$19.37$26.34
16 Aug 2024$19.88$19.44$25.77
30 Aug 2024$21.88$19.79$25.41
13 Sep 2024$19.27$20.29$25.09
27 Sep 2024$21.33$20.17$24.76
11 Oct 2024$19.00$19.90$24.33
25 Oct 2024$17.27$19.56$23.90
8 Nov 2024$21.78$19.68$23.48
22 Nov 2024$19.65$19.44$22.81
6 Dec 2024$20.48$19.49$22.28
20 Dec 2024$20.56$20.02$21.78
3 Jan 2025$23.68$20.58$21.49
17 Jan 2025$22.85$21.35$21.14
31 Jan 2025$22.41$21.41$20.79
14 Feb 2025$19.54$21.76$20.46
28 Feb 2025$18.64$21.62$20.21
14 Mar 2025$20.03$21.30$20.19
28 Mar 2025$20.29$21.00$20.30
11 Apr 2025$21.91$20.68$20.42
25 Apr 2025$21.59$20.74$20.58
9 May 2025$24.00$21.03$20.60
23 May 2025$22.31$21.75$20.79
6 Jun 2025$23.74$21.98$20.91
20 Jun 2025$23.29$22.70$21.09
3 Jul 2025$24.59$23.22$21.27
18 Jul 2025$24.90$23.98$21.53
1 Aug 2025$25.12$24.34$21.85
15 Aug 2025$22.62$24.45$22.10
29 Aug 2025$23.01$24.18$22.21
12 Sep 2025$26.42$24.26$22.45
26 Sep 2025$25.66$24.54$22.78
10 Oct 2025$23.85$24.48$22.93
24 Oct 2025$26.11$24.83$23.08
7 Nov 2025$24.10$25.34$23.21
21 Nov 2025$22.38$24.87$23.24
5 Dec 2025$22.11$24.19$23.36
19 Dec 2025$20.53$23.33$23.41
2 Jan 2026$20.58$22.71$23.40
16 Jan 2026$19.75$21.77$23.39
30 Jan 2026$15.58$20.67$23.25
13 Feb 2026$16.01$19.28$22.93
27 Feb 2026$15.52$18.20$22.65
13 Mar 2026$14.99$17.15$22.24
27 Mar 2026$13.43$15.88$21.83
10 Apr 2026$13.52$15.02$21.36
24 Apr 2026$16.18$15.00$20.89
8 May 2026$18.23$15.33$20.50
22 May 2026$18.01$15.82$20.13
5 Jun 2026$18.46$16.47$19.95
18 Jun 2026$17.54$17.12$19.71
2 Jul 2026$19.00$17.67$19.37
17 Jul 2026$19.17$18.23$19.02
31 Jul 2026$19.85$18.56$18.76
14 Aug 2026$21.06$19.02$18.52
28 Aug 2026$21.03$19.92$18.37
11 Sep 2026$20.90$20.48$18.30
25 Sep 2026$21.13$20.92$18.25
9 Oct 2026$19.40$21.02$18.22
23 Oct 2026$19.49$20.76$18.13
4 Nov 2026$13.44$20.17$18.04
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 5-year window.

Price stage: Sideways from Oct 2025 to Mar 2026; Falling from Mar 2026 to Jul 2026; Sideways from Jul 2026 to Nov 2026.

Price stage: Sideways from Nov 2023 to Jan 2024; Rising from Jan 2024 to Mar 2024; Sideways from Apr 2024 to Jun 2024; Falling from Jun 2024 to Dec 2024; Sideways from Jan 2025 to Jul 2025; Rising from Aug 2025 to Nov 2025; Sideways from Dec 2025 to Mar 2026; Falling from Mar 2026 to Jul 2026; Sideways from Jul 2026 to Nov 2026.

Price stage: Sideways from Dec 2022 to Mar 2023; Rising from Mar 2023 to Nov 2023; Sideways from Nov 2023 to Jan 2024; Rising from Feb 2024 to Mar 2024; Sideways from Apr 2024 to Jun 2024; Falling from Jun 2024 to Dec 2024; Sideways in Jan 2025; Falling from Feb 2025 to Mar 2025; Sideways from Apr 2025 to Jul 2025; Rising from Aug 2025 to Nov 2025; Sideways from Nov 2025 to Mar 2026; Falling from Mar 2026 to Jul 2026; Sideways from Jul 2026 to Nov 2026.

Week by week since 2021: did it beat the S&P 500 over the past 13 weeks?

Ahead in 129 of 264 weeks

Week by week since 2021: did it beat the S&P 500 over the past 13 weeks?
Week13-week return vs S&P 500
23 Jul 2021no S&P 500 reading
30 Jul 2021no S&P 500 reading
6 Aug 2021no S&P 500 reading
13 Aug 2021no S&P 500 reading
20 Aug 2021no S&P 500 reading
27 Aug 2021no S&P 500 reading
3 Sep 2021no S&P 500 reading
10 Sep 2021no S&P 500 reading
17 Sep 2021no S&P 500 reading
24 Sep 2021no S&P 500 reading
1 Oct 2021no S&P 500 reading
8 Oct 2021no S&P 500 reading
15 Oct 2021no S&P 500 reading
22 Oct 2021+19.3%
29 Oct 2021+22.4%
5 Nov 2021+12.0%
12 Nov 2021+2.4%
19 Nov 2021−12.5%
26 Nov 2021−12.9%
3 Dec 2021−17.4%
10 Dec 2021−21.0%
17 Dec 2021−16.0%
23 Dec 2021−24.7%
31 Dec 2021−18.2%
7 Jan 2022−31.7%
14 Jan 2022−33.6%
21 Jan 2022−22.6%
28 Jan 2022−32.0%
4 Feb 2022−23.8%
11 Feb 2022−17.5%
18 Feb 2022−21.8%
25 Feb 2022−22.8%
4 Mar 2022−21.8%
11 Mar 2022−21.4%
18 Mar 2022−22.1%
25 Mar 2022−17.5%
1 Apr 2022−5.1%
8 Apr 2022+13.8%
14 Apr 2022+21.9%
22 Apr 2022−7.1%
29 Apr 2022+3.7%
6 May 2022−5.3%
13 May 2022−1.3%
20 May 2022+16.2%
27 May 2022+8.7%
3 Jun 2022+2.7%
10 Jun 2022+4.6%
17 Jun 2022−1.3%
24 Jun 2022+1.7%
1 Jul 2022−8.2%
8 Jul 2022−9.5%
15 Jul 2022−13.4%
22 Jul 2022−1.7%
29 Jul 2022+6.9%
5 Aug 2022+20.4%
12 Aug 2022+12.6%
19 Aug 2022−12.3%
26 Aug 2022+5.5%
2 Sep 2022+5.3%
9 Sep 2022+15.8%
16 Sep 2022+15.7%
23 Sep 2022+9.3%
30 Sep 2022+16.4%
7 Oct 2022+21.9%
14 Oct 2022+31.6%
21 Oct 2022+27.6%
28 Oct 2022+4.6%
4 Nov 2022−13.6%
11 Nov 2022−8.7%
18 Nov 2022−6.3%
25 Nov 2022−13.4%
2 Dec 2022−6.4%
9 Dec 2022−2.9%
16 Dec 2022+1.1%
23 Dec 2022+2.9%
30 Dec 2022−1.0%
6 Jan 2023+6.7%
13 Jan 2023−6.1%
20 Jan 2023+0.2%
27 Jan 2023+15.6%
3 Feb 2023+29.0%
10 Feb 2023+27.6%
17 Feb 2023+43.4%
24 Feb 2023+44.8%
3 Mar 2023+59.4%
10 Mar 2023+36.7%
17 Mar 2023+30.5%
24 Mar 2023+26.9%
31 Mar 2023+37.1%
6 Apr 2023+22.3%
14 Apr 2023+34.1%
21 Apr 2023+33.3%
28 Apr 2023+27.9%
5 May 2023+37.0%
12 May 2023+37.5%
19 May 2023+24.4%
26 May 2023+19.0%
2 Jun 2023+6.3%
9 Jun 2023+17.2%
16 Jun 2023+27.2%
23 Jun 2023+28.2%
30 Jun 2023+16.7%
7 Jul 2023+17.3%
14 Jul 2023+8.8%
21 Jul 2023+12.3%
28 Jul 2023+7.7%
4 Aug 2023+14.1%
11 Aug 2023+7.2%
18 Aug 2023+10.5%
25 Aug 2023+16.5%
1 Sep 2023+11.3%
8 Sep 2023+0.7%
15 Sep 2023−10.2%
22 Sep 2023−14.4%
29 Sep 2023−4.7%
6 Oct 2023+3.6%
13 Oct 2023+8.6%
20 Oct 2023+2.9%
27 Oct 2023+2.3%
3 Nov 2023−16.1%
10 Nov 2023−9.5%
17 Nov 2023−15.5%
24 Nov 2023−17.3%
1 Dec 2023−19.4%
8 Dec 2023−11.3%
15 Dec 2023−9.5%
22 Dec 2023−9.8%
29 Dec 2023−19.4%
5 Jan 2024−27.4%
12 Jan 2024−26.9%
19 Jan 2024−24.8%
26 Jan 2024−8.2%
2 Feb 2024+10.2%
9 Feb 2024+0.2%
16 Feb 2024+5.7%
23 Feb 2024+3.7%
1 Mar 2024+7.2%
8 Mar 2024−5.7%
15 Mar 2024−2.7%
22 Mar 2024+3.4%
28 Mar 2024+7.6%
5 Apr 2024−0.7%
12 Apr 2024−0.8%
19 Apr 2024−8.3%
26 Apr 2024−17.5%
3 May 2024−23.4%
10 May 2024−37.0%
17 May 2024−40.6%
24 May 2024−42.2%
31 May 2024−40.5%
7 Jun 2024−40.9%
14 Jun 2024−47.2%
21 Jun 2024−47.1%
28 Jun 2024−46.9%
5 Jul 2024−43.0%
12 Jul 2024−35.8%
19 Jul 2024−30.9%
26 Jul 2024−35.9%
2 Aug 2024−31.6%
9 Aug 2024−8.9%
16 Aug 2024−8.7%
23 Aug 2024−13.0%
30 Aug 2024+0.8%
6 Sep 2024+13.6%
13 Sep 2024+4.9%
20 Sep 2024+3.9%
27 Sep 2024+11.3%
4 Oct 2024−0.9%
11 Oct 2024−16.0%
18 Oct 2024−20.8%
25 Oct 2024−18.2%
1 Nov 2024−5.2%
8 Nov 2024−5.4%
15 Nov 2024−10.1%
22 Nov 2024−0.3%
29 Nov 2024−15.4%
6 Dec 2024−16.6%
13 Dec 2024+13.5%
20 Dec 2024+2.7%
27 Dec 2024−2.8%
3 Jan 2025+21.5%
10 Jan 2025+20.6%
17 Jan 2025+22.5%
24 Jan 2025+19.7%
31 Jan 2025+9.0%
7 Feb 2025+0.3%
14 Feb 2025−1.2%
21 Feb 2025+5.6%
28 Feb 2025−5.6%
7 Mar 2025+10.5%
14 Mar 2025−7.2%
21 Mar 2025+14.1%
28 Mar 2025+0.5%
4 Apr 2025−5.0%
11 Apr 2025+3.5%
17 Apr 2025+7.6%
25 Apr 2025+9.7%
2 May 2025+1.2%
9 May 2025+15.5%
16 May 2025+25.5%
23 May 2025+10.2%
30 May 2025+20.0%
6 Jun 2025+6.1%
13 Jun 2025+11.1%
20 Jun 2025−1.9%
27 Jun 2025+10.8%
3 Jul 2025+5.5%
11 Jul 2025−1.7%
18 Jul 2025−5.3%
25 Jul 2025+7.1%
1 Aug 2025+7.8%
8 Aug 2025−14.4%
15 Aug 2025−14.1%
22 Aug 2025−10.0%
29 Aug 2025−5.8%
5 Sep 2025−6.3%
12 Sep 2025+2.4%
19 Sep 2025+3.4%
26 Sep 2025−3.5%
3 Oct 2025−1.4%
10 Oct 2025−10.1%
17 Oct 2025−7.7%
24 Oct 2025−7.8%
31 Oct 2025−9.3%
7 Nov 2025−3.3%
14 Nov 2025−6.8%
21 Nov 2025−3.2%
28 Nov 2025−4.4%
5 Dec 2025−14.4%
12 Dec 2025−24.9%
19 Dec 2025−25.9%
26 Dec 2025−23.6%
2 Jan 2026−22.9%
9 Jan 2026−18.0%
16 Jan 2026−23.3%
23 Jan 2026−35.6%
30 Jan 2026−39.7%
6 Feb 2026−38.6%
13 Feb 2026−29.0%
20 Feb 2026−32.9%
27 Feb 2026−33.9%
6 Mar 2026−28.4%
13 Mar 2026−25.1%
20 Mar 2026−24.2%
27 Mar 2026−27.0%
2 Apr 2026−29.3%
10 Apr 2026−33.7%
17 Apr 2026−24.0%
24 Apr 2026−9.9%
1 May 2026+9.5%
8 May 2026+10.8%
15 May 2026+3.9%
22 May 2026+4.1%
29 May 2026+10.0%
5 Jun 2026+10.1%
12 Jun 2026+1.9%
18 Jun 2026+5.0%
26 Jun 2026+17.9%
2 Jul 2026+24.8%
10 Jul 2026+33.8%
17 Jul 2026+18.8%
24 Jul 2026+18.1%
31 Jul 2026+8.4%
7 Aug 2026+6.4%
14 Aug 2026+12.0%
21 Aug 2026+22.8%
28 Aug 2026+11.0%
4 Sep 2026+6.7%
11 Sep 2026+19.3%
18 Sep 2026+21.7%
25 Sep 2026+12.6%
2 Oct 2026+3.0%
9 Oct 2026−4.1%
16 Oct 2026−4.1%
23 Oct 2026−3.8%
30 Oct 2026−3.5%
4 Nov 2026−32.9%
Each bar is one week, from 2021 to now (264 weeks with a reading). Green means the stock's return over the previous 13 weeks beat the S&P 500; red means it trailed. The colour is strongest at a gap of 25 percentage points or more. A gap means there is no reading for that week.

Over the last 5.3 years the share price moved −34% while the S&P 500 moved +74%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 2 October 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

What dividend does Stevanato Group S.p.A. pay?

Stevanato Group S.p.A. has 2 quarters of declared dividends on file, too few for a 12-month total. The most recent declaration was $0.05 for Dec 2024.

A dividend is cash paid out for each share. The 12-month total is the four most recent quarters added together.

Stevanato Group S.p.A. declared a dividend in 2 of the last 12 reported quarters, most recently $0.05 for Dec 2024. That is fewer than four quarters, so no 12-month total is shown.

Dividend per share each quarter: latest $0.05 (Dec 2024)

  • Dividend per share $0.05
Dividend per share each quarter: latest $0.05 (Dec 2024)
QuarterDividend per share
Dec 2023$0.05
Dec 2024$0.05
Declared dividend per share, $ a share, each reported quarter. 2 quarters on file.

Which stock lists is Stevanato Group S.p.A. on?

Stevanato Group S.p.A. is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list.

Is Stevanato Group S.p.A. profitable?

Stevanato Group S.p.A. earned $23.0 M of net profit in the Jun 2026 quarter, −22.7% on the same quarter a year earlier. Full-year FY25 profit was $140 M. Over 4 years profit has grown 1.0% a year on average. That is 7.6% of the quarter's revenue. The same quarter a year earlier earned $29.7 M.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY25 profit was $140 M (+18.7% on the year before).

FY25 profit $140 M (+18.7% on the year before), 1.0% a year over 4 years

  • Net profit $140 M
FY25 profit $140 M (+18.7% on the year before), 1.0% a year over 4 years
QuarterNet profit
FY21$134 M
FY22$143 M
FY23$146 M
FY24$118 M
FY25$140 M

Growth on a year earlier

  • Growth on a year earlier 18.7%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY226.5%
FY231.9%
FY24−19.2%
FY2518.7%
Top: net profit each year, $ M. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jun 2026: $23.0 M (−22.7% on a year earlier)

  • Net profit (quarterly) $23.0 M
Jun 2026: $23.0 M (−22.7% on a year earlier)
QuarterNet profit (quarterly)
Sep 2023$37.9 M
Dec 2023$45.2 M
Mar 2024$18.8 M
Jun 2024$20.6 M
Sep 2024$30.0 M
Dec 2024$48.3 M
Mar 2025$26.5 M
Jun 2025$29.7 M
Sep 2025$36.1 M
Dec 2025$47.6 M
Mar 2026$28.0 M
Jun 2026$23.0 M

Growth on a year earlier

  • Growth on a year earlier −22.7%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 20234.6%
Dec 2023−6.5%
Mar 2024−33.4%
Jun 2024−39.8%
Sep 2024−20.8%
Dec 20246.8%
Mar 202540.9%
Jun 202544%
Sep 202520.1%
Dec 2025−1.6%
Mar 20265.7%
Jun 2026−22.7%
Top: net profit each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Why profit moved: revenue changed +7.8% on a year earlier and the margin moved +2.2 percentage points. Most of the change came from keeping more of each sale.

On average over the last four quarters, profit changed +0.4% and revenue +7.1%. Profit is growing slower than sales: rising costs are taking part of the growth.

How much revenue does Stevanato Group S.p.A. make, and is it growing?

Stevanato Group S.p.A. reported $302 M of revenue in the Jun 2026 quarter, +7.8% on the same quarter a year earlier. That is the 9th quarter in a row with growth on the year before. Over 4 years it has grown 8.9% a year on average. The last full year, FY25, came in at $1.2 B.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to $1.2 B.

FY25 revenue was $1.2 B, +7.4% on the year before.

FY25 revenue $1.2 B (+7.4% on the year before), 8.9% a year over 4 years

  • Revenue $1.2 B
FY25 revenue $1.2 B (+7.4% on the year before), 8.9% a year over 4 years
QuarterRevenue
FY21$844 M
FY22$984 M
FY23$1.1 B
FY24$1.1 B
FY25$1.2 B

Growth on a year earlier

  • Growth on a year earlier 7.4%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY2216.6%
FY2310.3%
FY241.7%
FY257.4%
Top: revenue each year, $ B. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jun 2026: $302 M (+7.8% on a year earlier), the 9th quarter in a row of growth

  • Revenue (quarterly) $302 M
Jun 2026: $302 M (+7.8% on a year earlier), the 9th quarter in a row of growth
QuarterRevenue (quarterly)
Sep 2023$271 M
Dec 2023$321 M
Mar 2024$236 M
Jun 2024$260 M
Sep 2024$278 M
Dec 2024$331 M
Mar 2025$257 M
Jun 2025$280 M
Sep 2025$303 M
Dec 2025$346 M
Mar 2026$274 M
Jun 2026$302 M

Growth on a year earlier

  • Growth on a year earlier 7.8%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 202310.7%
Dec 20239.8%
Mar 2024−0.8%
Jun 20241.7%
Sep 20242.4%
Dec 20243.1%
Mar 20258.7%
Jun 20257.9%
Sep 20259.1%
Dec 20254.8%
Mar 20266.6%
Jun 20267.8%
Top: revenue each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Recent pace: the last four quarters grew +7.1% on average, against 8.9% a year over the longer run, so this year is growing slower than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +7.0%, against +6.1% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +0.0%, against +4.8% a year (rolling over).

How much of every $100 of sales does Stevanato Group S.p.A. keep?

Stevanato Group S.p.A.'s operating margin was 17.2% in the Jun 2026 quarter, 2.2 percentage points higher than the same quarter a year ago. Across 5 years it has been between 15.2% and 19.6%. The latest quarter is within that range.

Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed +2.2 percentage points on the year while gross margin changed +0.8 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales.

FY25: 17.2%, within a range of 15.2% to 19.6% over 5 years

  • Operating margin 17.2%
FY25: 17.2%, within a range of 15.2% to 19.6% over 5 years
QuarterOperating margin
FY2119.2%
FY2219.6%
FY2318.5%
FY2415.2%
FY2517.2%

Change on the year before (points)

  • Change on the year before (points) +2.0 pts
Change on the year before (points)
QuarterChange on the year before (points)
FY21–
FY22+0.4 pts
FY23−1.1 pts
FY24−3.3 pts
FY25+2.0 pts
Operating margin each year, % (top). Below: change on the year before, in percentage points. 5-year window.

Jun 2026: operating margin 17.2% (+2.2 points on a year earlier)

  • Operating margin 17.2%
Jun 2026: operating margin 17.2% (+2.2 points on a year earlier)
QuarterOperating margin
Sep 202318.8%
Dec 202320%
Mar 202411.1%
Jun 202411.6%
Sep 202415%
Dec 202420.4%
Mar 202514%
Jun 202515%
Sep 202517.7%
Dec 202520.9%
Mar 202614.2%
Jun 202617.2%

Change on a year earlier (points)

  • Change on a year earlier (points) +2.2 pts
Change on a year earlier (points)
QuarterChange on a year earlier (points)
Sep 2023+0.1 pts
Dec 2023−4.2 pts
Mar 2024−6.0 pts
Jun 2024−5.9 pts
Sep 2024−3.8 pts
Dec 2024+0.4 pts
Mar 2025+2.9 pts
Jun 2025+3.4 pts
Sep 2025+2.7 pts
Dec 2025+0.5 pts
Mar 2026+0.2 pts
Jun 2026+2.2 pts
Top: quarterly operating margin, %. Below: change on the same quarter a year earlier, in percentage points. Last 12 quarters. Operating profit as a share of revenue, each quarter.

Is Stevanato Group S.p.A.'s profit turning into cash?

Over the last 3 years, 136% of Stevanato Group S.p.A.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $286 M of operating cash against $140 M of profit. After $264 M of spending on assets, $22.3 M was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

FY25: operating cash $286 M against profit $140 M; 136% of 3 years' profit came in as cash

  • Operating cash $286 M
  • Net profit $140 M
  • Free cash $22.3 M
FY25: operating cash $286 M against profit $140 M; 136% of 3 years' profit came in as cash
QuarterOperating cashNet profitFree cash
FY21$133 M$134 M$25.6 M
FY22$103 M$143 M−$132 M
FY23$105 M$146 M−$328 M
FY24$156 M$118 M−$147 M
FY25$286 M$140 M$22.3 M
Operating cash flow and net profit each year, $ M. The line is free cash flow: operating cash minus spending on assets. 5-year window, yearly figures.

Jun 2026: operating cash $31.9 M = 139% of the quarter's profit

  • Operating cash (quarterly) $31.9 M
Jun 2026: operating cash $31.9 M = 139% of the quarter's profit
QuarterOperating cash (quarterly)
Sep 2023$33.5 M
Dec 2023$10.2 M
Mar 2024$71.6 M
Jun 2024$22.3 M
Sep 2024$18.3 M
Dec 2024$43.6 M
Mar 2025$99.8 M
Jun 2025$44.9 M
Sep 2025$47.2 M
Dec 2025$94.1 M
Mar 2026$75.5 M
Jun 2026$31.9 M

Operating cash as % of profit

  • Operating cash as % of profit 139%
Operating cash as % of profit
QuarterOperating cash as % of profit
Sep 202388%
Dec 202323%
Mar 2024381%
Jun 2024108%
Sep 202461%
Dec 202490%
Mar 2025377%
Jun 2025151%
Sep 2025131%
Dec 2025198%
Mar 2026269%
Jun 2026139%
Top: operating cash each quarter, $ M. Below: operating cash as a % of net profit; 100% means all of the quarter's profit came in as cash. Last 12 quarters.

Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.

What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building.

Where does Stevanato Group S.p.A.'s cash go?

Stevanato Group S.p.A. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $1,000 M on assets over the last 3 years. Averaged over those years that is 28.1% of FY25 revenue a year.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.

Spending on assets: $1,000 M over the last 3 years.

FY25: capex $264 M, steady spending

  • Capex $264 M
FY25: capex $264 M, steady spending
QuarterCapex
FY21$108 M
FY22$235 M
FY23$433 M
FY24$303 M
FY25$264 M
Capital spending each year, $ M.

Jun 2026: capex $57.6 M in the quarter

  • Capex (quarterly) $57.6 M
Jun 2026: capex $57.6 M in the quarter
QuarterCapex (quarterly)
Sep 2023$131 M
Dec 2023$82.0 M
Mar 2024$101 M
Jun 2024$68.7 M
Sep 2024$44.5 M
Dec 2024$88.9 M
Mar 2025$70.4 M
Jun 2025$57.6 M
Sep 2025$46.4 M
Dec 2025$89.3 M
Mar 2026$66.3 M
Jun 2026$57.6 M

Free cash

  • Free cash −$25.8 M
Free cash
QuarterFree cash
Sep 2023−$97.8 M
Dec 2023−$71.8 M
Mar 2024−$28.9 M
Jun 2024−$46.5 M
Sep 2024−$26.2 M
Dec 2024−$45.2 M
Mar 2025$29.5 M
Jun 2025−$12.7 M
Sep 2025$0.8 M
Dec 2025$4.8 M
Mar 2026$9.2 M
Jun 2026−$25.8 M
Top: capital spending each quarter, $ M. Below: free cash flow, $ M. Last 12 quarters.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

What is Stevanato Group S.p.A.'s P/E ratio, and how does it compare with its own history?

Stevanato Group S.p.A.'s P/E is 23.2×, with too little history to compare. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.

P/E 23.2× against a usual —: with too little history to compare

  • P/E 28.0×
P/E 23.2× against a usual —: with too little history to compare
WeekP/E
1 Apr 202242.4×
14 Apr 202241.7×
29 Apr 202233.5×
13 May 202232.0×
27 May 202235.2×
10 Jun 202231.1×
24 Jun 202233.8×
8 Jul 202233.7×
22 Jul 202233.4×
5 Aug 202240.3×
19 Aug 202236.6×
2 Sep 202236.3×
16 Sep 202238.4×
30 Sep 202232.6×
14 Oct 202235.6×
28 Oct 202232.6×
11 Nov 202229.6×
25 Nov 202228.6×
9 Dec 202232.2×
23 Dec 202234.4×
6 Jan 202337.6×
20 Jan 202336.8×
3 Feb 202336.8×
17 Feb 202339.9×
3 Mar 202347.7×
17 Mar 202343.5×
31 Mar 202348.0×
14 Apr 202349.7×
28 Apr 202349.2×
12 May 202351.4×
26 May 202349.5×
9 Jun 202353.8×
23 Jun 202359.5×
7 Jul 202357.5×
21 Jul 202359.5×
4 Aug 202359.4×
18 Aug 202356.0×
1 Sep 202359.7×
15 Sep 202353.1×
29 Sep 202353.7×
13 Oct 202359.4×
27 Oct 202351.6×
10 Nov 202351.5×
24 Nov 202350.2×
8 Dec 202350.0×
22 Dec 202349.2×
5 Jan 202448.2×
19 Jan 202451.9×
2 Feb 202459.7×
16 Feb 202458.0×
1 Mar 202459.7×
15 Mar 202454.9×
28 Mar 202458.8×
12 Apr 202457.7×
26 Apr 202454.1×
10 May 202442.9×
24 May 202439.2×
7 Jun 202436.6×
21 Jun 202435.0×
5 Jul 202440.6×
19 Jul 202446.9×
2 Aug 202442.1×
16 Aug 202443.6×
30 Aug 202448.0×
13 Sep 202442.3×
27 Sep 202446.8×
11 Oct 202444.6×
25 Oct 202440.5×
8 Nov 202451.1×
22 Nov 202446.1×
6 Dec 202448.1×
20 Dec 202448.3×
3 Jan 202555.7×
17 Jan 202553.8×
31 Jan 202552.7×
14 Feb 202546.0×
28 Feb 202543.9×
14 Mar 202547.1×
28 Mar 202547.7×
11 Apr 202548.5×
25 Apr 202547.8×
9 May 202553.1×
23 May 202549.4×
6 Jun 202552.5×
20 Jun 202551.5×
3 Jul 202550.7×
18 Jul 202551.3×
1 Aug 202551.8×
15 Aug 202546.6×
29 Aug 202547.4×
12 Sep 202554.5×
26 Sep 202552.9×
10 Oct 202547.2×
24 Oct 202551.7×
7 Nov 202547.7×
21 Nov 202544.3×
5 Dec 202543.8×
19 Dec 202540.6×
2 Jan 202640.7×
16 Jan 202639.0×
30 Jan 202630.8×
13 Feb 202631.6×
27 Feb 202630.7×
13 Mar 202629.6×
27 Mar 202626.5×
10 Apr 202626.6×
24 Apr 202631.8×
8 May 202635.8×
22 May 202635.4×
5 Jun 202636.3×
18 Jun 202634.5×
2 Jul 202639.6×
17 Jul 202639.9×
31 Jul 202641.4×
14 Aug 202643.9×
28 Aug 202643.8×
11 Sep 202643.5×
25 Sep 202644.0×
9 Oct 202640.4×
23 Oct 202640.6×
4 Nov 202628.0×

Earnings per share, 12 months

  • Earnings per share, 12 months $0.48
Earnings per share, 12 months
WeekEarnings per share, 12 months
1 Apr 2022–
14 Apr 2022–
29 Apr 2022–
13 May 2022–
27 May 2022–
10 Jun 2022–
24 Jun 2022$0.48
8 Jul 2022$0.48
22 Jul 2022$0.48
5 Aug 2022$0.48
19 Aug 2022$0.48
2 Sep 2022$0.48
16 Sep 2022$0.48
30 Sep 2022$0.52
14 Oct 2022$0.52
28 Oct 2022$0.52
11 Nov 2022$0.52
25 Nov 2022$0.52
9 Dec 2022$0.52
23 Dec 2022$0.52
6 Jan 2023$0.52
20 Jan 2023$0.52
3 Feb 2023$0.52
17 Feb 2023$0.52
3 Mar 2023$0.52
17 Mar 2023$0.52
31 Mar 2023$0.54
14 Apr 2023$0.54
28 Apr 2023$0.54
12 May 2023$0.54
26 May 2023$0.54
9 Jun 2023$0.54
23 Jun 2023$0.55
7 Jul 2023$0.55
21 Jul 2023$0.55
4 Aug 2023$0.55
18 Aug 2023$0.55
1 Sep 2023$0.55
15 Sep 2023$0.55
29 Sep 2023$0.55
13 Oct 2023$0.55
27 Oct 2023$0.55
10 Nov 2023$0.55
24 Nov 2023$0.55
8 Dec 2023$0.55
22 Dec 2023$0.55
5 Jan 2024$0.56
19 Jan 2024$0.56
2 Feb 2024$0.56
16 Feb 2024$0.56
1 Mar 2024$0.56
15 Mar 2024$0.56
28 Mar 2024$0.55
12 Apr 2024$0.55
26 Apr 2024$0.55
10 May 2024$0.55
24 May 2024$0.55
7 Jun 2024$0.55
21 Jun 2024$0.51
5 Jul 2024$0.51
19 Jul 2024$0.51
2 Aug 2024$0.51
16 Aug 2024$0.51
30 Aug 2024$0.51
13 Sep 2024$0.51
27 Sep 2024$0.46
11 Oct 2024$0.46
25 Oct 2024$0.46
8 Nov 2024$0.46
22 Nov 2024$0.46
6 Dec 2024$0.46
20 Dec 2024$0.46
3 Jan 2025$0.43
17 Jan 2025$0.43
31 Jan 2025$0.43
14 Feb 2025$0.43
28 Feb 2025$0.43
14 Mar 2025$0.43
28 Mar 2025$0.42
11 Apr 2025$0.42
25 Apr 2025$0.42
9 May 2025$0.42
23 May 2025$0.42
6 Jun 2025$0.42
20 Jun 2025$0.42
3 Jul 2025$0.45
18 Jul 2025$0.45
1 Aug 2025$0.45
15 Aug 2025$0.45
29 Aug 2025$0.45
12 Sep 2025$0.45
26 Sep 2025$0.48
10 Oct 2025$0.48
24 Oct 2025$0.48
7 Nov 2025$0.48
21 Nov 2025$0.48
5 Dec 2025$0.48
19 Dec 2025$0.48
2 Jan 2026$0.51
16 Jan 2026$0.51
30 Jan 2026$0.51
13 Feb 2026$0.51
27 Feb 2026$0.51
13 Mar 2026$0.51
27 Mar 2026$0.51
10 Apr 2026$0.51
24 Apr 2026$0.51
8 May 2026$0.51
22 May 2026$0.51
5 Jun 2026$0.51
18 Jun 2026$0.51
2 Jul 2026$0.51
17 Jul 2026$0.51
31 Jul 2026$0.51
14 Aug 2026$0.51
28 Aug 2026$0.51
11 Sep 2026$0.51
25 Sep 2026$0.48
9 Oct 2026$0.48
23 Oct 2026$0.48
4 Nov 2026$0.48
Top: P/E each week. Below: earnings per share, trailing twelve months, a step line that moves once a quarter; 4.6 years of history; short peaks above 60× are drawn at the top edge.

PEG 1.48 at the Jun 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate

  • PEG 1.48×
  • PEG = 1.0 1.00×
PEG 1.48 at the Jun 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate
QuarterPEGPEG = 1.0
Sep 20214.35×1.00×
Dec 20213.81×1.00×
Mar 20223.64×1.00×
Jun 20222.81×1.00×
Sep 20221.91×1.00×
Dec 20221.86×1.00×
Mar 20231.95×1.00×
Jun 20232.82×1.00×
Sep 20233.18×1.00×
Dec 20232.48×1.00×
Mar 20242.55×1.00×
Jun 20241.89×1.00×
Sep 20242.16×1.00×
Dec 20246.00×1.00×
Mar 20251.96×1.00×
Jun 20252.00×1.00×
Sep 20251.96×1.00×
Dec 20251.53×1.00×
Mar 20261.14×1.00×
Jun 20261.48×1.00×
PEG each quarter: the P/E divided by the yearly growth rate of earnings. The flat line marks 1.0. Below it the P/E is smaller than the growth rate; above it the P/E is bigger. Last 20 quarters; values above 6 are drawn at the top edge.
23.2×P/E · too little history to compare
1.40PEG · today, as reported

Why the multiple is where it is: over the past year earnings per share moved +18.6% while the price moved −44.2%. Earnings did better than the price, which pulled the multiple down within its own range.

Where the price move came from: over 3 years the price moved −20.4% a year; about −4.8% a year came from earnings growth and about −15.6 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple.

Is the Stevanato Group S.p.A. business getting better or worse?

Stevanato Group S.p.A.'s business is giving mixed signals. There is no clear direction across the growth lines, with ROCE steady at 11.1%; each line tells part of the story. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Growth year by year: revenue +7.4% in FY25, profit +18.7%

  • Revenue growth 7.4%
Growth year by year: revenue +7.4% in FY25, profit +18.7%
QuarterRevenue growth
FY21–
FY2216.6%
FY2310.3%
FY241.7%
FY257.4%

Profit growth, EPS growth

  • Profit growth 18.7%
  • EPS growth 18.6%
Profit growth, EPS growth
QuarterProfit growthEPS growth
FY21––
FY226.5%1.8%
FY231.9%1.9%
FY24−19.2%−21.8%
FY2518.7%18.6%
Growth on the year before, each year, %. Top: revenue. Below: net profit and earnings per share, on their own scale because profit growth swings much more. Zero line drawn.

Three growth lines over twelve quarters: revenue stabilising, profit rolling over

  • Revenue 7%
Three growth lines over twelve quarters: revenue stabilising, profit rolling over
QuarterRevenue
Sep 202314.4%
Dec 202310.3%
Mar 20247.3%
Jun 20245.5%
Sep 20243.5%
Dec 20241.7%
Mar 20253.8%
Jun 20255.3%
Sep 20257%
Dec 20257.4%
Mar 20267%
Jun 20267%

Profit, EPS

  • Profit 0%
  • EPS −1.1%
Profit, EPS
QuarterProfitEPS
Sep 20236.9%7%
Dec 20231.9%2.6%
Mar 2024−5%−5.5%
Jun 2024−16.7%−17.6%
Sep 2024−22.9%−23.5%
Dec 2024−19.1%−22.2%
Mar 2025−7.9%−11.2%
Jun 20259.8%6.6%
Sep 202522.6%18.8%
Dec 202518.7%19%
Mar 202612.6%12.5%
Jun 20260%−1.1%
Growth on a year earlier, % at each quarter end. Top: revenue. Below: profit and earnings per share, on their own scale because they swing much more. Each is measured over the last 12 months. A gap means there is no reading for that quarter.

ROCE: the return line, worked out each quarter

  • ROCE 11.1%
ROCE: the return line, worked out each quarter
QuarterROCE
Sep 202316.2%
Dec 202314.9%
Mar 202412.6%
Jun 202411.7%
Sep 202410.4%
Dec 20249.9%
Mar 20259.8%
Jun 202510.5%
Sep 202510.8%
Dec 202510.6%
Mar 202610.7%
Jun 202611.1%
Operating profit over the last 12 months (before interest and tax) as a share of average capital employed (total assets minus current liabilities), %.
Steady highRevenue growth · latest +7.0%, range +1.7% to +14.4%
FallingProfit growth · latest +0.0%, range −22.9% to +22.6%
FallingEPS growth · latest −1.1%, range −23.5% to +19.0%
Stuck lowROCE · latest 11.1%, range 9.8% to 16.2%

Why it matters: when the lines disagree, each line above matters more than any single label.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Compound annual growth rate (%)
Measure1yr3yr5yr10yr
Revenue+7.4%+6.4%——
Profit+18.7%−0.7%——
EPS+18.6%−1.9%——
Stock price−44.2%−20.4%−11.2%—
+7.8%Revenue growth (Jun 2026) · latest quarter against a year ago
−22.7%Profit growth (Jun 2026) · latest quarter against a year ago
8.9%Revenue, 4 years · yearly growth over the long run

How much does Stevanato Group S.p.A. earn on its capital?

Stevanato Group S.p.A. earned a ROE of 9% in FY25. That is up from a low of 8% in FY24. Its return on capital used (ROIC) is 0.4 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 11.8% net margin and 0.47× asset turnover (sales divided by assets).

Return on equity (ROE) is the profit the business earns on its shareholders’ money. We do not have the full capital split, so ROE is the longest history we can draw here.

Why the return is what it is (FY25): a 11.8% net margin × 0.47× asset turnover × 1.71× leverage (assets divided by equity) ≈ 9.5% on equity. The margin does its share; borrowing is a big part of it.

The key test, return on capital used minus the cost of capital: 8.1% − 7.7% = +0.4 percentage points. The 7.7% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error.

FY25: ROE 9%, the climb back from FY24's 8%

  • ROE 9.4%
  • ROIC (annual) 8.5%
  • Cost of capital 7.7%
FY25: ROE 9%, the climb back from FY24's 8%
QuarterROEROIC (annual)Cost of capital
FY2116%22.4%7.7%
FY2214.4%18.3%7.7%
FY2312.9%12.8%7.7%
FY248.4%7.7%7.7%
FY259.4%8.5%7.7%
Return on equity each year, % (line); ROIC each year, % (line). 5-year window, low years included. The flat line is the 7.7% cost of capital used on this page.

Jun 2026: ROIC 8.6% (last 12 months) against a 7.7% cost of capital

  • ROIC (12 months) 8.6%
  • ROE (12 months) 7.4%
  • Cost of capital 7.7%
Jun 2026: ROIC 8.6% (last 12 months) against a 7.7% cost of capital
QuarterROIC (12 months)ROE (12 months)Cost of capital
Sep 202316.2%13.2%7.7%
Dec 202315.1%14.1%7.7%
Mar 202412.9%16.2%7.7%
Jun 202411.1%6.1%7.7%
Sep 20249.4%6.2%7.7%
Dec 20248.2%9.1%7.7%
Mar 20257.6%14.2%7.7%
Jun 20257.9%7.5%7.7%
Sep 20258.4%8.4%7.7%
Dec 20258.8%10.2%7.7%
Mar 20268.7%13%7.7%
Jun 20268.6%7.4%7.7%
ROIC and ROE over the last 12 months, each quarter, %; the flat line is the cost of capital. Last 12 quarters, lined up with the yearly figure.

Does Stevanato Group S.p.A. have too much debt?

Stevanato Group S.p.A. has total debt of $445 M against shareholder equity of $1.5 B as of Jun 2026, so its debt is 0.29× its equity, which is very little. Year by year, that ratio went from 0.30 in FY21 to 0.32 in FY25. So the returns on this page come from the business, not from borrowed money.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

FY25: debt $470 M, 0.32× equity

  • Total debt $470 M
FY25: debt $470 M, 0.32× equity
QuarterTotal debt
FY21$248 M
FY22$219 M
FY23$397 M
FY24$430 M
FY25$470 M

Debt-to-equity

  • Debt-to-equity 0.32×
Debt-to-equity
QuarterDebt-to-equity
FY210.30×
FY220.22×
FY230.35×
FY240.31×
FY250.32×
Top: total debt each year, $ M. Below: debt-to-equity, ×. 5-year window.

Jun 2026: debt $445 M, debt-to-equity 0.29

  • Total debt (quarterly) $445 M
Jun 2026: debt $445 M, debt-to-equity 0.29
QuarterTotal debt (quarterly)
Sep 2023$296 M
Dec 2023$397 M
Mar 2024$374 M
Jun 2024$317 M
Sep 2024$363 M
Dec 2024$430 M
Mar 2025$394 M
Jun 2025$417 M
Sep 2025$451 M
Dec 2025$470 M
Mar 2026$451 M
Jun 2026$445 M

Debt-to-equity

  • Debt-to-equity 0.29×
Debt-to-equity
QuarterDebt-to-equity
Sep 20230.27×
Dec 20230.35×
Mar 20240.28×
Jun 20240.24×
Sep 20240.27×
Dec 20240.31×
Mar 20250.28×
Jun 20250.30×
Sep 20250.31×
Dec 20250.32×
Mar 20260.29×
Jun 20260.29×
Top: total debt each quarter, $ M. Below: debt-to-equity, ×. Last 12 quarters.

What is the Stevanato Group S.p.A. shareholding pattern?

2.0% of Stevanato Group S.p.A.'s tradable shares are in short positions, which are bets that the price will fall, so very few traders are betting against this stock. At normal trading volumes, closing those positions would take about 3.0 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.

There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.

It is a single reading at one point in time; we do not have its history.

2.0%Short interest · of the tradable float
3.0Days to cover · at typical volumes

Why it is at this level: the figure does not say who has the short positions or why, so we show the level without guessing the story.

How far is Stevanato Group S.p.A. from balance-sheet trouble?

For Stevanato Group S.p.A., the Z-score is 4.14. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

Why it matters: a Z-score of 4.14 is well clear of the danger zone, so the balance sheet is not the risk here.

How does Stevanato Group S.p.A. rank in its industry?

43.7 out of 100, rank 22 of 30 in Medical Instruments & Supplies, with 81% of the evidence available.

Stevanato Group S.p.A. scores 43.7 out of 100 against the 30 companies it is compared with in Medical Instruments & Supplies, ranking 22. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 17.1 + 16.1 + 10.5 + 0 = 43.7. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Which companies is Stevanato Group S.p.A. compared with?

Stevanato Group S.p.A. ranks 22 of 30 Medical Instruments & Supplies companies on the 4-Factor Sector Score, with 43.7 out of 100.

  1. 1West Pharmaceutical Services, Inc.WST · breaking out · Most evidence points up · 81% evidence67.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 23.5/35 · Revenue 12.4% · Profit 15.8% · Operating margin change 1.6 points · 83% evidenceCapital efficiency 20.6/25 · ROCE 21.2% · Operating margin 22.5% · 76% evidenceValuation 7.0/20 · P/E 44.9× · PEG 2.65 · 65% evidenceRelative strength 16.5/20 · Lead over its industry 10.3% · Lead over S&P 500 25.3% · 1 year 50.8% · 100% evidence · 5 of 12 weeks aheadExact sum: 23.5 + 20.6 + 7 + 16.5 = 67.6 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks.
  2. 2LeMaitre Vascular, Inc.LMAT · turning · Evidence leans up · 81% evidence63.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 26.7/35 · Revenue 11.5% · Profit 40.4% · Operating margin change 3.9 points · 83% evidenceCapital efficiency 17.3/25 · ROCE 11.9% · Operating margin 29% · 76% evidenceValuation 14.0/20 · P/E 33.4× · PEG 0.86 · 65% evidenceRelative strength 5.6/20 · Lead over its industry -22.3% · Lead over S&P 500 -11.1% · 1 year 1.3% · 100% evidence · 1 of 12 weeks aheadExact sum: 26.7 + 17.3 + 14 + 5.6 = 63.6 · What this means: Earnings are strong; relative strength in its sector is -22.3% and the one-year return is 1.3%.
  3. 3Intuitive Surgical, Inc.ISRG · breaking out · Evidence leans up · 85% evidence61.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 26.8/35 · Revenue 20.4% · Profit 7.7% · Operating margin change 3 points · 95% evidenceCapital efficiency 21.4/25 · ROCE 22% · Operating margin 33.3% · 76% evidenceValuation 4.5/20 · P/E 48.6× · PEG 5.33 · 65% evidenceRelative strength 9.1/20 · Lead over its industry -13.6% · Lead over S&P 500 -1.7% · 1 year -13.8% · 100% evidence · 4 of 12 weeks aheadExact sum: 26.8 + 21.4 + 4.5 + 9.1 = 61.8 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value.
  4. 4AtriCure, Inc.ATRC · leader · Evidence leans up · 64% evidence58.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 24.2/35 · Revenue 14% · Profit — · Operating margin change 10.8 points · 62% evidenceCapital efficiency 6.1/25 · ROCE 2.2% · Operating margin 6.3% · 76% evidenceValuation 8.9/20 · P/E 134.3× · PEG — · 15% evidenceRelative strength 19.6/20 · Lead over its industry 41.7% · Lead over S&P 500 59.4% · 1 year 104.5% · 100% evidence · 12 of 12 weeks aheadExact sum: 24.2 + 6.1 + 8.9 + 19.6 = 58.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  5. 5ResMed Inc.RMD · breaking out · Evidence leans up · 81% evidence58.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 17.8/35 · Revenue 9.8% · Profit 8.8% · Operating margin change -3 points · 83% evidenceCapital efficiency 21.5/25 · ROCE 25.4% · Operating margin 30.9% · 76% evidenceValuation 10.2/20 · P/E 18.5× · PEG 1.91 · 65% evidenceRelative strength 8.5/20 · Lead over its industry -13.6% · Lead over S&P 500 -1.9% · 1 year -4.4% · 100% evidence · 11 of 12 weeks aheadExact sum: 17.8 + 21.5 + 10.2 + 8.5 = 58 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  6. 6Merit Medical Systems, Inc.MMSI · losing its lead · Evidence leans up · 81% evidence57.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 22.0/35 · Revenue 10.3% · Profit 22.7% · Operating margin change 2.2 points · 83% evidenceCapital efficiency 14.3/25 · ROCE 8.1% · Operating margin 14.5% · 76% evidenceValuation 12.7/20 · P/E 28.4× · PEG 1.22 · 65% evidenceRelative strength 8.1/20 · Lead over its industry -4.7% · Lead over S&P 500 7.8% · 1 year 3.5% · 100% evidence · 10 of 12 weeks aheadExact sum: 22 + 14.3 + 12.7 + 8.1 = 57.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  7. 7Bausch + Lomb CorporationBLCO · turning · Evidence leans up · 64% evidence56.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 21.4/35 · Revenue 8.8% · Profit — · Operating margin change 6.8 points · 62% evidenceCapital efficiency 7.2/25 · ROCE 3.4% · Operating margin 7.7% · 76% evidenceValuation 11.5/20 · P/E -18.5× · PEG — · 15% evidenceRelative strength 15.9/20 · Lead over its industry 1.5% · Lead over S&P 500 15.3% · 1 year 32.5% · 100% evidence · 8 of 12 weeks aheadExact sum: 21.4 + 7.2 + 11.5 + 15.9 = 56 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  8. 8Kestra Medical Technologies, Ltd.KMTS · breaking out · Evidence leans up · 64% evidence54.9out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 25.1/35 · Revenue 63.6% · Profit — · Operating margin change 27.5 points · 71% evidenceCapital efficiency 3.4/25 · ROCE -48% · Operating margin -121.6% · 76% evidenceValuation 10.0/20 · P/E — · PEG — · 0% evidenceRelative strength 16.4/20 · Lead over its industry 4.3% · Lead over S&P 500 18.1% · 1 year 16.3% · 100% evidence · 9 of 12 weeks aheadExact sum: 25.1 + 3.4 + 10 + 16.4 = 54.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  9. 9Becton, Dickinson and CompanyBDX · leader · Evidence leans up · 71% evidence51.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 14.2/35 · Revenue 5.8% · Profit -40.6% · Operating margin change -1.4 points · 83% evidenceCapital efficiency 13.6/25 · ROCE 7.6% · Operating margin 15.7% · 76% evidenceValuation 9.6/20 · P/E 44.3× · PEG — · 15% evidenceRelative strength 13.7/20 · Lead over its industry -1.6% · Lead over S&P 500 11.4% · 1 year 17.5% · 100% evidence · 12 of 12 weeks aheadExact sum: 14.2 + 13.6 + 9.6 + 13.7 = 51.1 · What this means: Relative strength against the index is 11.4%, and revenue and profit growth are weak.
  10. 10STAAR Surgical CompanySTAA · turning · Too little evidence to rank firmly · 58% evidence50.2out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 18.2/35 · Revenue — · Profit — · Operating margin change -15 points · 45% evidenceCapital efficiency 12.8/25 · ROCE 10.3% · Operating margin 10.9% · 76% evidenceValuation 8.6/20 · P/E 360.4× · PEG — · 15% evidenceRelative strength 10.6/20 · Lead over its industry -6.6% · Lead over S&P 500 6.8% · 1 year 2.3% · 100% evidence · 1 of 12 weeks aheadExact sum: 18.2 + 12.8 + 8.6 + 10.6 = 50.2 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose.
  11. 11Baxter International Inc.BAX · quiet · Evidence leans down · 64% evidence49.9out of 100GrowthCapitalValuationRelative
  12. 12The Cooper Companies, Inc.COO · basing · Evidence leans down · 85% evidence49.3out of 100GrowthCapitalValuationRelative
  13. 13Solventum CorporationSOLV · turning · Evidence leans down · 71% evidence48.5out of 100GrowthCapitalValuationRelative
  14. 14Avantor, Inc.AVTR · leader · Evidence leans down · 71% evidence48.3out of 100GrowthCapitalValuationRelative
  15. 15Repligen CorporationRGEN · leader · Evidence leans down · 74% evidence46.8out of 100GrowthCapitalValuationRelative
  16. 16Azenta, Inc.AZTA · leader · Evidence leans down · 64% evidence46.7out of 100GrowthCapitalValuationRelative
  17. 17Alcon Inc.ALC · turning · Evidence leans down · 61% evidence45.1out of 100GrowthCapitalValuationRelative
  18. 18Align Technology, Inc.ALGN · quiet · Evidence leans down · 81% evidence44.4out of 100GrowthCapitalValuationRelative
  19. 19AptarGroup, Inc.ATR · turning · Evidence leans down · 81% evidence44.4out of 100GrowthCapitalValuationRelative
  20. 20Envista Holdings CorporationNVST · quiet · Too little evidence to rank firmly · 58% evidence44.4out of 100GrowthCapitalValuationRelative
  21. 21Teleflex IncorporatedTFX · turning · Evidence leans down · 71% evidence43.8out of 100GrowthCapitalValuationRelative
  22. 22Stevanato Group S.p.A. this pageSTVN · quiet · Evidence leans down · 81% evidence43.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 17.1/35 · Revenue 6.9% · Profit 0% · Operating margin change 2.2 points · 83% evidenceCapital efficiency 16.1/25 · ROCE 10.6% · Operating margin 17.2% · 76% evidenceValuation 10.5/20 · P/E 32.1× · PEG 1.73 · 65% evidenceRelative strength 0.0/20 · Lead over its industry -40.2% · Lead over S&P 500 -32% · 1 year -44.2% · 100% evidence · 6 of 12 weeks aheadExact sum: 17.1 + 16.1 + 10.5 + 0 = 43.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  23. 23ICU Medical, Inc.ICUI · quiet · Evidence leans down · 64% evidence38.7out of 100GrowthCapitalValuationRelative
  24. 24Medline Inc.MDLN · turning · Too little evidence to rank firmly · 51% evidence37.3out of 100GrowthCapitalValuationRelative
  25. 25DENTSPLY SIRONA Inc.XRAY · basing · Most evidence points down · 64% evidence31.7out of 100GrowthCapitalValuationRelative
  26. 26Warby Parker Inc.WRBY · quiet · Most evidence points down · 64% evidence28.7out of 100GrowthCapitalValuationRelative
  27. 27BioLife Solutions, Inc.BLFS · Too little evidence to rank firmly · 44% evidence48.0out of 100GrowthCapitalValuationRelative
  28. 28Pulse Biosciences, Inc.PLSE · leader · Too little evidence to rank firmly · 41% evidence44.5out of 100GrowthCapitalValuationRelative
  29. 29MiniMed Group, Inc.MMED · quiet · Too little evidence to rank firmly · 41% evidence39.1out of 100GrowthCapitalValuationRelative
  30. 30Alamar Biosciences, Inc.ALMR · quiet · Too little evidence to rank firmly · 28% evidence38.8out of 100GrowthCapitalValuationRelative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Medical Instruments & Supplies, all 30 compared on one page.

Which companies are close to Stevanato Group S.p.A. in size?

Stevanato Group S.p.A. is the 21st largest of 38 Medical Instruments & Supplies companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: Envista Holdings Corporation, ICU Medical, Inc. and Pulse Biosciences, Inc. Just below it: AtriCure, Inc., Warby Parker Inc. and DENTSPLY SIRONA Inc.

Medical Instruments & Supplies companies close in size

  1. Envista Holdings Corporation $4.4 billion
  2. ICU Medical, Inc. $4.3 billion
  3. Pulse Biosciences, Inc. $4.1 billion
  4. Stevanato Group S.p.A. $3.7 billion
  5. AtriCure, Inc. $3.3 billion
  6. Warby Parker Inc. $2.6 billion
  7. DENTSPLY SIRONA Inc. $2.1 billion

All 38 Medical Instruments & Supplies companies, largest first

Companies close in size in other industries

  1. Hamilton Insurance Group, Ltd. $3.7 billion · Insurance - Reinsurance
  2. Renasant Corporation $3.7 billion · Banks - Regional
  3. Stevanato Group S.p.A. $3.7 billion
  4. Kyndryl Holdings, Inc. $3.7 billion · Information Technology Services
  5. Curbline Properties Corp. $3.7 billion · REIT - Retail

What else do people ask about Stevanato Group S.p.A.?

What were Stevanato Group S.p.A.'s latest quarterly results?

Stevanato Group S.p.A. reported revenue of $302 M and net profit of $23.0 M for the Jun 2026 quarter. Revenue rose 7.8% and profit fell 22.7% compared with a year earlier. Earnings per share were $0.08.

The operating margin was 17.2%, 2.2 percentage points higher than a year earlier (as of 4 November 2026).

What is Stevanato Group S.p.A.'s market cap?

Stevanato Group S.p.A.'s market capitalisation is $3.7 B at a stock price of $13.44. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026).

How is Stevanato Group S.p.A. performing?

Stevanato Group S.p.A.'s share price has been falling for 1 weeks. In its latest quarter, revenue rose 7.8% and profit fell 22.7% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 5 weeks running (as of 4 November 2026).

Will Stevanato Group S.p.A.'s stock price go up?

This page does not forecast Stevanato Group S.p.A.'s stock price. What it shows instead: the stock price is $13.44, and it has been falling for 1 weeks. Nobody can reliably say which way a price will move, and this site does not try (as of 4 November 2026).

Where is Stevanato Group S.p.A. in its business cycle?

Stevanato Group S.p.A.'s FY25 operating margin was 17.2%, against a 5-year range of 15.2% to 19.6%: the middle of its own range, neither a peak nor a low. The latest quarter was 17.2%.

Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026).

What could break the Stevanato Group S.p.A. story?

The main question: yearly earnings per share moved +18.6% while the share price moved −44.2%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026).

Is Stevanato Group S.p.A. a stock worth studying right now?

What the numbers show: Stevanato Group S.p.A.'s earnings have grown faster than its share price. Earnings per share grew +18.6% in a year while the price moved −44.2%. The main open question: whether the price catches up with earnings that have already grown.

Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026).

Where do these numbers come from?

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.

More lists

Every Sector Alpha list, grouped

X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.